January 27, 2015 9:40 PM ET

Healthcare Providers and Services

Company Overview of Acadia Healthcare Company, Inc.

Company Overview

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, and substance abuse facilities in the United States. Its acute inpatient psychiatric facilities provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses; and residential treatment centers offer intensive, medically-driven interventions, and individualized treatment to patient with moderate to high level acuity. The company also operates therapeutic group homes that provide treatment services for seriously, emotionally disturbed adolescents; and manages therapeutic foster care programs for children and adolescents with emotional d...

830 Crescent Centre Drive

Suite 610

Franklin, TN 37067

United States

Founded in 2005

7,500 Employees

Phone:

615-861-6000

Key Executives for Acadia Healthcare Company, Inc.

Chairman and Chief Executive Officer
Age: 61
Total Annual Compensation: $660.0K
President
Age: 48
Total Annual Compensation: $435.0K
Chief Financial Officer
Age: 34
Total Annual Compensation: $327.0K
Chief Operating Officer
Age: 61
Total Annual Compensation: $450.0K
Executive Vice President
Age: 47
Total Annual Compensation: $420.0K
Compensation as of Fiscal Year 2013.

Acadia Healthcare Company, Inc. Key Developments

Acadia Healthcare Company, Inc. Enters into Sixth Amendment to its Amended and Restated Credit Agreement

On December 15, 2014, Acadia Healthcare Company, Inc. entered into a Sixth Amendment to its Amended and Restated Credit Agreement, dated as of December 31, 2012. Pursuant to the Sixth Amendment, the company incurred $235,000,000 of additional term loans. A portion of the Additional Term Loan Advance was used to prepay the company's outstanding revolving loans. The Sixth Amendment also specifically permits the acquisition of CRC Health Group, Inc., a Delaware corporation, through the merger of a newly-formed wholly-owned subsidiary of the company with and into CRC. In connection with the CRC Acquisition, the Sixth Amendment also: imposes a temporary reserve on the company's revolving credit facility in the amount of $110,000,000 in order to preserve such reserved amounts for later borrowings to partially fund the consideration for the CRC Acquisition; permits the incurrence of an additional incremental term loan facility under the Amended and Restated Credit Agreement partially to fund the consideration for the CRC Acquisition; and permits the issuance by the company of additional senior unsecured indebtedness or senior unsecured bridge indebtedness partially to fund the consideration for the CRC Acquisition. The company's baskets for permitted investments were also increased to provide increased flexibility for the company to invest in non-wholly owned subsidiaries, joint ventures and foreign subsidiaries. The company may invest in non-wholly owned subsidiaries and joint ventures up to 7.5% of the total assets of the company and its subsidiaries in any fiscal year, and up to 10% of the total assets of the company and its subsidiaries during the term of the Amended and Restated Credit Agreement (provided that secured intercompany loans from a loan party to a joint venture will not count against such basket). The company may also invest in foreign subsidiaries that are not loan parties up to 10% of the total assets of the Company and its subsidiaries in any fiscal year, and up to 15% of the total assets of the company and its subsidiaries during the term of the Amended and Restated Credit Agreement. The foregoing permitted investments are subject to an aggregate cap of 20% of the total assets of the company and its subsidiaries in any fiscal year. The Sixth Amendment also permits the company, subject to certain consents, to add one or more foreign borrowers and/or request revolving loans and letters of credit in foreign currencies.

Acadia Healthcare Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Revises Earnings Guidance for the Year 2014; Provides Tax Rate Guidance for the Fourth Quarter of 2014

Acadia Healthcare Company, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $294,479,000 against $184,702,000 a year ago. Income from continuing operations before income taxes was $33,156,000 against $22,287,000 a year ago. Income from continuing operations was $25,453,000 or $0.43 per basic and diluted share against $14,546,000 or $0.29 per basic and diluted share a year ago. Net income was $25,402,000 or $0.43 per diluted share against $14,364,000 or $0.29 per basic and diluted share a year ago. EBITDA was $57,549,000 against $36,166,000 a year ago. Adjusted EBITDA was $65,066,000 against $38,481,000 a year ago. Adjusted income from continuing operations was $27,265,000 or $0.46 per diluted share against $15,189,000 or $0.30 per diluted share a year ago. Operating cash flows totaled $22 million. For the nine months, the company reported revenue of $709,700,000 against $523,409,000 a year ago. Income from continuing operations before income taxes was $91,314,000 against $49,310,000 a year ago. Income from continuing operations was $60,931,000 or $1.13 per diluted share against $30,871,000 or $0.61 per diluted share a year ago. Net income was $60,911,000 or $1.13 per diluted share against $30,299,000 or $0.60 per diluted share a year ago. Net cash provided by operating activities was $69,046,000 against $46,228,000 a year ago. Cash paid for capital expenditures was $70,680,000 against $50,678,000 a year ago. EBITDA was $146,515,000 against $89,230,000 a year ago. Adjusted EBITDA was $149,062,000 against $106,137,000 a year ago. Adjusted income from continuing operations was $57,870,000 or $1.07 per diluted share against $39,114,000 or $0.78 per diluted share a year ago. For the fourth quarter, the company expects tax rate to be approximately 28%. The company raised its guidance for 2014 adjusted earnings per diluted share to a range of $1.52 to $1.53 from the previous range of $1.44 to $1.46. The company's guidance does not include the impact of any future acquisitions or transaction-related expenses.

Acadia Healthcare Company, Inc. Presents at Stephens Inc. Fall Investment Conference 2014, Nov-11-2014 11:00 AM

Acadia Healthcare Company, Inc. Presents at Stephens Inc. Fall Investment Conference 2014, Nov-11-2014 11:00 AM. Venue: New York Palace Hotel, 455 Madison Avenue, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Washington Manor, Inc. United States
Jensen's, Inc. United States
Prime Medical Operating, Inc. United States
Ide Imaging Partners Inc United States
Diagnostica Stago, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 4, 2014
Belmont Center For Comprehensive Treatment
Merger/Acquisition
October 29, 2014
CRC Health Group, Inc.
Merger/Acquisition
September 11, 2014
McCallum Place Eating Disorder Centers
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Acadia Healthcare Company, Inc., please visit www.acadiahealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.